News mentioning ENHERTU
21 stories
Jul 21, 26‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx deal
Jul 9, 26STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more
Jul 8, 26Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
May 8, 26Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer